Iris Neoplasm — Trials

Iris Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–12 of 12 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01989572	Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery	completed	Phase 3	815	National Cancer Institute (NCI)NIH	1	Jun 24, 2026	clinicaltrials
NCT05628883	Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma	completed	Phase 1	17	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Apr 2, 2026	clinicaltrials
NCT01413191	Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye	completed	Phase 2	18	National Cancer Institute (NCI)NIH	1	Feb 19, 2020	clinicaltrials
NCT01100528

Data updated 22 days agoSource updated Jun 24, 2026source: clinicaltrials